These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16794212)

  • 1. Neglecting the difference: does right or left matter in stroke outcome after thrombolysis?
    Di Legge S; Saposnik G; Nilanont Y; Hachinski V
    Stroke; 2006 Aug; 37(8):2066-9. PubMed ID: 16794212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis in right versus left hemispheric stroke.
    Blondin NA; Staff I; Lee N; McCullough LD
    J Stroke Cerebrovasc Dis; 2010; 19(4):269-72. PubMed ID: 20471856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: a hospital-based study from south India.
    Boddu DB; Srinivasarao Bandaru VC; Reddy PG; Madhusudan M; Rukmini MK; Suryaprabha T; Jabeen SA; Suvarna A; Jayalakshmi SS; Meena AK; Borgohain R; Kaul S
    Neurol India; 2010; 58(3):403-6. PubMed ID: 20644268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke.
    Brown DL; Johnston KC; Wagner DP; Haley EC
    Stroke; 2004 Jan; 35(1):147-50. PubMed ID: 14657446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.
    Betts KA; Hurley D; Song J; Sajeev G; Guo J; Du EX; Paschoalin M; Wu EQ
    J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke.
    Kim DH; Lee DS; Nah HW; Cha JK
    BMC Neurol; 2018 Mar; 18(1):30. PubMed ID: 29544461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple clinical predictors of stroke outcome based on National Institutes of Health Stroke scale score during 1-h recombinant tissue-type plasminogen activator infusion.
    Osaki M; Miyashita F; Koga M; Fukuda M; Shigehatake Y; Nagatsuka K; Minematsu K; Toyoda K
    Eur J Neurol; 2014 Mar; 21(3):411-8. PubMed ID: 24200315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of major neurologic improvement after thrombolysis in acute stroke.
    Saposnik G; Di Legge S; Webster F; Hachinski V
    Neurology; 2005 Oct; 65(8):1169-74. PubMed ID: 16247041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Combination of Clinical Features, Transcranial Doppler, and Alberta Stroke Program Early Computed Tomography Score (Computed Tomography Angiography) in Predicting Outcome in Intravenous Recombinant Tissue Plasminogen Activator-Treated Patients.
    Saqqur M; Ghrooda E; Ahmad A; Khan K; Hussain MS; Shuaib A
    J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):2019-23. PubMed ID: 27241578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in the use of intravenous thrombolysis for mild stroke: experience across the SPOTRIAS network.
    Willey JZ; Khatri P; Khoury JC; Merino JG; Ford AL; Rost NS; Gonzales NR; Ali LK; Meyer BC; Broderick JP
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):318-22. PubMed ID: 22177935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependence of NIHSS in predicting functional outcome of patients with acute ischemic stroke treated with intravenous thrombolysis.
    Wu Z; Zeng M; Li C; Qiu H; Feng H; Xu X; Zhang H; Wu J
    Postgrad Med J; 2019 Apr; 95(1122):181-186. PubMed ID: 30975729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
    Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of systemic thrombolysis within 4.5 h from stroke symptom onset: a single-centre clinical and diffusion-perfusion 3T MRI study.
    Floris R; Cozzolino V; Meschini A; Garaci F; Konda D; Marziali S; Sallustio F; Di Legge S; Claroni G; Fanucci E; Simonetti G; Stanzione P
    Radiol Med; 2014 Oct; 119(10):767-74. PubMed ID: 24567091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA: SAMURAI rt-PA Registry.
    Nezu T; Koga M; Kimura K; Shiokawa Y; Nakagawara J; Furui E; Yamagami H; Okada Y; Hasegawa Y; Kario K; Okuda S; Nishiyama K; Naganuma M; Minematsu K; Toyoda K
    Neurology; 2010 Aug; 75(6):555-61. PubMed ID: 20697108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early neurologic improvement based on the National Institutes of Health Stroke Scale score predicts favorable outcome within 30 minutes after undergoing intravenous recombinant tissue plasminogen activator therapy.
    Takagi T; Kato T; Sakai H; Nishimura Y
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):69-74. PubMed ID: 23164483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of Stroke Diagnosis in Telestroke-Guided Tissue Plasminogen Activator Patients.
    Agrawal K; Raman R; Ernstrom K; Claycomb RJ; Meyer DM; Hemmen TM; Modir RF; Kachhi P; Meyer BC
    J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2942-2946. PubMed ID: 27599906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.
    Alvarez-Sabín J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M
    Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke.
    Patel SC; Levine SR; Tilley BC; Grotta JC; Lu M; Frankel M; Haley EC; Brott TG; Broderick JP; Horowitz S; Lyden PD; Lewandowski CA; Marler JR; Welch KM;
    JAMA; 2001 Dec; 286(22):2830-8. PubMed ID: 11735758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience.
    Rhoney DH; Coplin WM; Lin Y; Frankel M; Lyden PD; Levine SR
    J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):40-8. PubMed ID: 20123226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.